Turcotte, Anne-Frédérique
Grenier-Larouche, Thomas
Ung, Roth-Visal
Simonyan, David
Carreau, Anne-Marie
Carpentier, André C.
Mac-Way, Fabrice
Michou, Laetitia
Tchernof, André
Biertho, Laurent
Lebel, Stefane
Marceau, Simon
Gagnon, Claudia
Funding for this research was provided by:
Canadian Institutes of Health Research (MOP 97947)
Canadian Diabetes Association (NC-3-17-5232-CG)
Fondation CHU de Québec
Article History
First Online: 26 November 2018
Compliance with Ethical Standards
:
: AMC is the recipient of Fonds de recherche du Québec-Santé (FRQ-S) and Diabetes Canada scholarships. ACC is the recipient of the GSK Chair in Diabetes of Université de Sherbrooke. LM reports non-financial support from Roche Diagnostics Canada, personal fees from Amgen, personal fees from Eli Lilly, personal fees from Abbvie, personal fees from Bristol-Myers Squibb, personal fees from Novartis, outside the submitted work. AT and LB receive funding from Johnson Johnson Medical Companies and Medtronic for research studies on bariatric surgery. CG is a clinical research scholar of the FRQ-S and the recipient of a Diabetes Canada New Investigator Award. She received research funding from Technologies Khlôros, and speaker honoraria from Amgen, Eli Lilly, and Janssen. All other authors report no conflicts of interest.